✦ LIBER ✦

Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study

✍ Scribed by Jinn-Ming Chang; Wen-Sheng Tzeng; Huay-Ben Pan; Chien-Fang Yang; Kwok-Hung Lai

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 454 KB
Volume: 74
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19941101)74:9<2449::aid-cncr2820740910>3.0.co;2-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with transcatheter a

Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma : A randomized control study

✍ Masahiko Koda; Yoshikazu Murawaki; Akeri Mitsuda; Kenji Oyama; Kinya Okamoto; Yo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

The safety and efficacy of transcatheter

The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction : A prospective controlled study

✍ Hyo-Suk Lee; Joo Sung Kim; Il Ju Choi; Jin Wook Chung; Jae Hyung Park; Chung Yon 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Background: Transcatheter arterial chemoembolization (tace) has been contra-indicated for the treatment of patients with hepatocellular carcinoma (hcc) and main portal vein (mpv) obstruction because of the potential risk of hepatic insufficiency resulting from ischemia after tace. the current co

Treatment of patients with advanced gast

Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen : Two parallel randomized phase II studies

✍ Carlo Barone; Domenico C. Corsi; Carmelo Pozzo; Alessandra Cassano; Tecla Fontan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

370 mg/m 2 , on Days 1-5 and 36 others in Study B received epirubicin, 30 mg/m 2 , cina Interna e Geriatria, Universita `Cattolica del on Days 1 and 5; etoposide, 100 mg/m 2 , on Days 1, 3, and 5; cisplatin, 30 mg/m 2 , S. Cuore, Rome, Italy. on Days 2 and 4; and lonidamine, 150 mg/day. ## RESULTS